Your browser doesn't support javascript.
loading
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review.
Sharafi, Faezeh; Hasani, Sadegh Abaei; Alesaeidi, Samira; Kahrizi, Mohammad Saeed; Adili, Ali; Ghoreishizadeh, Shadi; Shomali, Navid; Tamjidifar, Rozita; Aslaminabad, Ramin; Akbari, Morteza.
Affiliation
  • Sharafi F; Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hasani SA; Cancer Research Center, Department of General Surgery, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Alesaeidi S; Department of Internal Medicine and Rheumatology, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Kahrizi MS; Alborz University of Medical Sciences, Karaj, Iran.
  • Adili A; Senior Adult Oncology Department, Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA.
  • Ghoreishizadeh S; Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Shomali N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tamjidifar R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Aslaminabad R; Department of Medical Biochemistry, Faculty of Medicine, Ege University, Izmir, 35100, Turkey.
  • Akbari M; Department of Stem Cell, Institute of Health Sciences, Ege University, Izmir, 35100, Turkey.
Cancer Cell Int ; 22(1): 269, 2022 Aug 23.
Article de En | MEDLINE | ID: mdl-35999569
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline Langue: En Journal: Cancer Cell Int Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline Langue: En Journal: Cancer Cell Int Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: Royaume-Uni